基于我院和国内部分地区的国家基本药物使用现状及其优先使用相关因素研究

发布时间：2018-07-06 17:01

本文选题：国家基本药物 + 使用金额　；参考：《中国药房》2015年30期

【摘要】：目的:了解国家基本药物的使用现状,为进一步贯彻落实国家基本药物制度、促进国家基本药物的优先使用提供参考。方法:通过对我院及北京、上海、广州地区国家基本药物的使用情况(分别以抗高血压药和口服降糖药为例)进行统计分析,探讨与国家基本药物优先使用相关的影响因素。结果:我院2012-2013年国家基本药物使用金额占药品总使用金额的比例分别为21.20%和18.75%,呈下降趋势;抗高血压药类国家基本药物使用金额仅占全部抗高血压药的14.05%和13.70%;缬沙坦胶囊、比索洛尔片、氨氯地平片的普通GMP产品与其同通用名的单独定价药品相比在用药频度(DDDs)上并无优势甚至处于劣势。北京地区各级医疗卫生机构以及上海、广州地区三级医院2011-2012年阿卡波糖片的单独定价药品DDDs远远高于其同通用名的普通GMP产品。结论:国家基本药物在我院及国内部分地区的临床应用水平还有待进一步提高,影响其优先使用的因素包括医保报销机制、相关知识知晓率、医师用药习惯、追求经济效益等几个方面。应加强宣传、培训,提高医务人员及公众对国家基本药物的知晓率;提高国家基本药物的可及性;完善国家基本药物制度和医保报销制度,多措施联合应用促进国家基本药物的优先使用。
[Abstract]:Objective: to understand the current situation of the use of essential drugs in China, and to provide a reference for carrying out the national essential drug system and promoting the priority use of national essential drugs. Methods: the use of essential drugs in our hospital and in Beijing, Shanghai and Guangzhou (taking antihypertensive drugs and oral hypoglycemic drugs as examples) was statistically analyzed, and the influencing factors related to the priority use of essential drugs in China were discussed. Results: in 2012-2013, the proportion of national essential drug use in our hospital was 21.20% and 18.75%, respectively, showing a downward trend, while the amount of essential drugs used in antihypertensive drugs accounted for 14.05% and 13.70% of the total antihypertensive drugs, valsartan capsule, valsartan capsule, Bisoprolol tablets and amlodipine tablets have no advantages or even disadvantages in DDDs compared with their common name single priced drugs. The DDDs of Acarbose tablets in Beijing and Shanghai and Guangzhou hospitals in 2011-2012 are much higher than those of their generic GMP products. Conclusion: the level of clinical application of national essential drugs in our hospital and some parts of China needs to be further improved. The factors affecting the priority use of essential drugs include the reimbursement mechanism of medical insurance, the awareness rate of relevant knowledge, the habit of using medicine by doctors. Pursue economic benefits and other aspects. Publicity and training should be strengthened to increase the awareness of medical personnel and the public about the country's essential drugs; to improve the accessibility of national essential drugs; and to improve the national essential drug system and the medical insurance reimbursement system. Combined use of multiple measures to promote national priority use of essential drugs.
【作者单位】：首都医科大学宣武医院药剂科;
【基金】：国家卫生和计划生育委员会药政司资助课题
【分类号】：R95

【参考文献】